Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations

Evans AH 1 , Okai D 2 , Weintraub D 3 , Lim SY 4 , O'Sullivan SS 4 , Voon V 5 Show all authors , Krack P 6 , Sampaio C 7 , Post B 8 , Leentjens AFG 9 , Martinez-Martin P 10 , Stebbins GT 11 , Goetz CG 11 , Schrag A 12 , Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee

Affiliations 

  • 1 Department of Neurology, the Royal Melbourne Hospital, Parkville, Australia
  • 2 Kings College London, Institute of Psychiatry, Section of Cognitive Neuropsychiatry, London, UK
  • 3 Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • 4 Division of Neurology, Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 5 Department of Psychiatry, University of Cambridge, Cambridge, UK
  • 6 Movement Disorders Center, Department of Neurology, University Hospital (Inselspital) and University of Bern, Bern Switzerland
  • 7 Cure Huntington's Disease InitiativeEl (CHDI) Management/CHDI Foundation, Princeton, New Jersey, USA
  • 8 Department of Neurology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • 9 Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands
  • 10 National Center of Epidemiology and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Carlos III Institute of Health, Madrid, Spain
  • 11 Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
  • 12 Department of Clinical Neurosciences, Institute of Neurology, University College London, London, UK
Mov Disord, 2019 06;34(6):791-798.
PMID: 31136681 DOI: 10.1002/mds.27689

Abstract

Impulse control disorders (ICDs) and related impulsive and compulsive behaviors (together called ICBs) have been increasingly recognized in the context of Parkinson's disease (PD) and treatment. The International Parkinson's and Movement Disorder Society commissioned a task force to assess available clinical screening instruments and rating scales, including their clinimetric properties, make recommendations regarding their utility, and suggest future directions in scale development and validation. The literature was systematically searched for scales measuring a range of reported ICBs in PD. A scale was designated "recommended" if the scale had been employed in PD studies, been used beyond the group that developed it, and had adequate clinimetric data published for PD. Numerous diagnostic screening tools and severity rating scales were identified for a range of ICBs, including compulsive medication use, punding/hobbyism, walkabout, pathological gambling, hypersexuality, compulsive or binge eating, compulsive buying, reckless driving, compulsive exercise, pyromania, trichotillomania, hoarding, kleptomania, intermittent explosive disorder, and internet addiction. For screening across the range of ICBs (except compulsive medication use), the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease (QUIP) and QUIP-Rating Scale (QUIP-RS) are recommended, and for severity rating across the range of ICBs the QUIP-RS and the Ardouin Scale of Behavior in Parkinson's Disease are recommended. The Scale for Outcomes in Parkinson's Disease-Psychiatric Complications is recommended for rating of hypersexuality and the compulsive behaviors gambling/shopping. Further testing of established scales against gold standard diagnostic criteria is urgently required for all other individual ICBs in PD. © 2019 International Parkinson and Movement Disorder Society © 2019 International Parkinson and Movement Disorder Society.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications